COVID-19 疫情期间急性肾损伤患者姑息治疗的使用情况
该回顾性分析基于纽约大学朗格尼健康中心2020年3月2日至2020年8月25日期间4276例COVID-19住院患者数据,其中1310例(31%)合并急性肾损伤。合并AKI患者接受姑息治疗会诊的调整比值比高于无AKI患者(未接受肾脏替代治疗者1.81,接受者2.45),但会诊时间更晚;尽管姑息治疗使用更多,AKI患者住院时间更长、ICU入住和机械通气更多。
要点
- COVID-19合并AKI患者接受姑息治疗的比例高于无AKI患者(调整OR 1.81至2.45)。
- AKI患者姑息治疗会诊时间更晚(入院后10天 vs 5天,P<0.001)。
- 姑息治疗会诊未与减少生命维持干预的启动相关。
核心结论
- 在COVID-19合并AKI患者中,姑息治疗的使用频率高于既往AKI报道,但会诊发生在住院病程较晚阶段,且未与减少生命维持干预的启动相关。
研究设计与样本
- 对纽约大学朗格尼健康中心2020年3月2日至2020年8月25日期间COVID-19住院患者电子健康数据的回顾性分析,共4276例,其中AKI 1310例(31%),无AKI 2966例(69%)。
- 使用回归模型检验与接受姑息治疗会诊相关的特征。
主要发现
- AKI未接受KRT患者接受姑息治疗的调整OR为1.81(95%CI 1.40至2.33,P<0.001),AKI接受KRT患者调整OR为2.45(95%CI 1.52至3.97,P<0.001),均以无AKI患者为参照。
- AKI患者姑息治疗会诊时间显著更晚(入院后10天 vs 5天,P<0.001)。
- 开始KRT的患者中66%接受姑息治疗,而未接受KRT的AKI患者中为37%(P<0.001),会诊时间也更晚(入院后12天 vs 9天,P=0.002)。
- 尽管姑息治疗使用更多,AKI患者住院时间显著更长、ICU入住更多、机械通气使用更多。
- AKI患者出院至住院临终关怀机构的比例更高(6% vs 3%),复苏状态变更的比例也更高(34% vs 7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: AKI is a common complication of coronavirus disease 2019 (COVID-19) and is associated with high mortality. Palliative care, a specialty that supports patients with serious illness, is valuable for these patients but is historically underutilized in AKI. The objectives of this paper are to describe the use of palliative care in patients with AKI and COVID-19 and their subsequent health care utilization. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted a retrospective analysis of New York University Langone Health electronic health data of COVID-19 hospitalizations between March 2, 2020 and August 25, 2020. Regression models were used to examine characteristics associated with receiving a palliative care consult. RESULTS: Among patients with COVID-19 (n=4276; 40%), those with AKI (n=1310; 31%) were more likely than those without AKI (n=2966; 69%) to receive palliative care (AKI without KRT: adjusted odds ratio, 1.81; 95% confidence interval, 1.40 to 2.33; P<0.001; AKI with KRT: adjusted odds ratio, 2.45; 95% confidence interval, 1.52 to 3.97; P<0.001), even after controlling for markers of critical illness (admission to intensive care units, mechanical ventilation, or modified sequential organ failure assessment score); however, consults came significantly later (10 days from admission versus 5 days; P<0.001). Similarly, 66% of patients initiated on KRT received palliative care versus 37% (P<0.001) of those with AKI not receiving KRT, and timing was also later (12 days from admission versus 9 days; P=0.002). Despite greater use of palliative care, patients with AKI had a significantly longer length of stay, more intensive care unit admissions, and more use of mechanical ventilation. Those with AKI did have a higher frequency of discharges to inpatient hospice (6% versus 3%) and change in code status (34% versus 7%) than those without AKI. CONCLUSIONS: Palliative care was utilized more frequently for patients with AKI and COVID-19 than historically reported in AKI. Despite high mortality, consultation occurred late in the hospital course and was not associated with reduced initiation of life-sustaining interventions. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2022_02_24_CJN11030821.mp3.
引用
- Scherer JS, Qian Y, Rau ME, et al. Utilization of Palliative Care for Patients with COVID-19 and Acute Kidney Injury during a COVID-19 Surge. Clin J Am Soc Nephrol. 2022. PMID: 35210281. doi:10.2215/CJN.11030821
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。